| Literature DB >> 28941651 |
Linda S Lee1, Dana K Andersen2, Reiko Ashida3, William R Brugge4, Mimi I Canto5, Kenneth J Chang6, Suresh T Chari7, John DeWitt8, Joo Ha Hwang9, Mouen A Khashab5, Kang Kim10, Michael J Levy7, Kevin McGrath11, Walter G Park12, Aatur Singhi13, Tyler Stevens14, Christopher C Thompson1, Mark D Topazian7, Michael B Wallace15, Sachin Wani16, Irving Waxman17, Dhiraj Yadav12, Vikesh K Singh5.
Abstract
A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to address the research gaps and opportunities in pancreatic EUS. The event occurred on July 26, 2017 in 4 sessions: (1) benign pancreatic diseases, (2) high-risk pancreatic diseases, (3) diagnostic and therapeutics, and (4) new technologies. The current state of knowledge was reviewed, with identification of numerous gaps in knowledge and research needs. Common themes included the need for large multicenter consortia of various pancreatic diseases to facilitate meaningful research of these entities; to standardize EUS features of different pancreatic disorders, the technique of sampling pancreatic lesions, and the performance of various therapeutic EUS procedures; and to identify high-risk disease early at the cellular level before macroscopic disease develops. The need for specialized tools and accessories to enable the safe and effective performance of therapeutic EUS procedures also was discussed.Entities:
Mesh:
Year: 2017 PMID: 28941651 PMCID: PMC6698378 DOI: 10.1016/j.gie.2017.08.006
Source DB: PubMed Journal: Gastrointest Endosc ISSN: 0016-5107 Impact factor: 9.427